Dermata (DRMA) receives Australian patent for topical botulinum toxin treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. SNOW
2. AVGO
3. RARE
4. HPE
5. FIVE
6. SPY
7. VRTS
8. NTAP
9. OLLI
10. NTSK

Go back to Dermata (DRMA) receives Australian patent for topical botulinum toxin treatment
(NASDAQ: DRMA) Delayed: 1.35 +0.07 (5.47%)
Previous Close $1.28    52 Week High $ 
Open $1.28    52 Week Low $ 
Day High $1.37    P/E N/A 
Day Low $1.27    EPS $ 
Volume 17,551       

(NASDAQ: DRMAW) Delayed: 0.00 --0 (-0%)
Previous Close $0.00    52 Week High $ 
Open $0.00    52 Week Low $ 
Day High $0.00    P/E N/A 
Day Low $0.00    EPS $ 
Volume 212,944